The next three to six months are dominated by one question the market actually cares about: does management re-open forward guidance in Q4 FY2026, and at what number. The company withdrew its ₹2,500 cr FY2026 revenue guide in Q1 FY2026 after US tariffs on its films stacked from 6.25% to 50%, and TTM revenue is now ₹2,071 cr and flat to down. Everything else on the calendar is secondary to that single data point.
No Results
Loading...
The near-term setup is unusually bimodal. If Q4 FY2026 lands with margin back above 20% and a specific FY2027 revenue number, the stock re-rates back toward its 30x P/E ceiling on the "tariff-shock survived" narrative. If margin stays near 18 to 19% and management extends the guidance silence for another quarter, the 30x multiple starts compressing toward the 20 to 22x it traded at in FY2023. Everything else on the calendar (TPU line, GAS studios, UAE) is a slow-compound. Guidance is the acute catalyst.
**The margin pivot is structural, not cyclical, and the market still taxes it like BOPET.** Warren's peer scatter shows Garware earning 20.6% ROCE against Polyplex at 7.2%, Jindal Poly at 5.4%, Ester at 6.5% — a 13-point gap that has held through two full BOPET cycles. 87% of revenue is now value-added (vs 28% in FY2017), and in the FY2024 collapse that cratered Polyplex margins 14 points and Jindal Poly 24 points, Garware gave back 2 points. The re-rating from 22x to 30x only partially reflects that this is a different business than its cost base suggests.
**Balance sheet gives them the runway to outlast the tariff cycle.** Quant confirms term debt fully retired, 643 cr net cash, net-debt/EBITDA near negative 1.3x; the 125 cr PPF-2 capex and 118 cr TPU capex together are about 38% of that cash pile. Sherlock notes zero promoter pledge, zero dilution in nine years, 5,623 cr of promoter stake locked in — so the fortress is funded by cash-flow and unlikely to be raided by a rights issue. In a tariff drawdown, they can fund the capacity build-out, absorb 3 to 4 quarters of pressured US demand, and keep the dividend — without touching the equity base.
**Tariff-shock Q3 FY2026 print already tested the thesis, and the machine held.** Warren notes management absorbed about 40 cr of a ~50 cr tariff hit through mix shift — higher IR-blocking SCF, premium PPF — while keeping EBITDA margin at 18.9% and growing Middle East from 4% to 8% in a year. A plain BOPET maker hit with a 25-point tariff step-up would have seen margins disappear; Garware's CPD mix absorbed it with 2 to 4 points of compression. This is the first real-world evidence that the PPF+SCF unit economics do what the bulls claimed.
**Institutional discovery is still early.** Sherlock's ownership chart shows FII holding rising from 0.0% (Mar-2021) to 3.96% (Dec-2025) — roughly 13x in 21 months, still negligible in absolute terms for a 9,300 cr mid-cap. Promoter holding is anchored at 60.73% with zero dilution. If Q4 FY2026 breaks the guidance silence with a real FY2027 number, the float has to be absorbed by incremental institutional buyers who have been accumulating at the margin, not by retail rotating out — the flow setup is favourable.
**The 2,500 cr FY2026 guidance was reaffirmed four consecutive quarters, then withdrawn — not restated.** Historian's credibility score of 6.5/10 rests on this specific pattern: management is better at disclosure than at lowering forecasts, and when the number slips they go silent rather than provide a replacement. TTM revenue at 2,071 cr versus a committed 2,500 cr is not a rounding error — it is a ~17% miss on a promise repeated through six calls. The next guidance number this company gives will be weighed against that history.
**30x P/E requires the 20%+ margin to hold, and Q3 FY2026 printed 15% operating margin.** Quant's bear case sees margin normalising to 15% FY27 and the multiple compressing to 22x on EPS of ~113 — implying ~2,500 price vs ~4,005 today. The current multiple sits in the top decile of Garware's 10-year range, while both the 25% plus/minus 3% committed margin band and the FY26 revenue target have been breached in the same fiscal year. If Q4 FY2026 also prints margin under 20%, the re-rating pillar is materially weaker.
**US concentration is a thesis-breaker that is structurally slow to fix.** Warren and Historian both flag US at 40% of revenue with Middle East/Europe collectively at 19% — the geographic rebalancing management is promising would require Middle East to double again and Europe to expand, which takes years of dealer/applicator build-out. A sustained 3 to 4 quarter demand drop in the US auto aftermarket (the most likely second-order effect of a 50% tariff) idles the new 600 LSF PPF line, delays the earnings lever that FY27/28 numbers depend on, and pushes the TPU line economics out another year.
**Succession is unresolved at 91, and promoter pay is rising faster than profit at the margin.** Sherlock flagged this explicitly: no named CEO successor, no ESOP for professional managers, and three promoter JMDs drew 37 cr in FY25 with +60 to 73% YoY hikes in a single year. Base salary (non-variable) jumped sharply. In a profit-compression scenario, the pay structure does not automatically normalise — commission is profit-linked but salary is not — and shareholders' only real reset mechanism is an AGM vote against a 60.73% promoter block. If a succession event arrives before guidance is restored, both legs of the multiple (execution and alignment) get tested at once.
I'd lean cautious here — not bearish, but unwilling to be long at 30x earnings in a quarter where operating margin printed 15% and management has chosen silence on forward numbers. The For side has the better structural story: the pivot is real, the balance sheet is genuinely fortress, and Q3 FY2026 proved the unit economics can absorb a 50% tariff without the margin collapse that hit every BOPET peer. But the Against side has the better near-term tape — the 30x multiple is pricing the 20%+ margin as permanent while the committed 25% plus/minus 3% band has already been breached and the headline revenue target was withdrawn rather than lowered. The specific item that tips the scale is the withdrawn FY2026 guidance: it is a credibility event, not a narrative event, and the multiple compressed less than the guidance did. The condition that would flip me constructive is a Q4 FY2026 print with EBITDA margin back above 20% and a specific, restated FY2027 revenue number — both in the same release. Until then, I'd rather watch the reopening of the guidance fog than pay a premium to the history.